GlycoEra AG

Swiss Biotech Association

Member

GlycoEra leverages its control over natural glycan-mediated pathways to advance novel drugs using its propriety platform, the CustumGlycan Platform. GlycoEra develops first in class therapeutics in inflammatory disease, autoimmune disorder and immuno-oncology indications.

https://glycoera.com/
+41 44 733 85 75
veronica.gambillara@glycoera.com
Veronica Gambillara Fonck

Location

Grabenstrasse 3, 8952 Schlieren, Zürich, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2020
Number of employees in Switzerland

10-19

Key business

Core competencies

You may also be interested in

TissueLabs Sagl

TissueLabs is the platform for creating organs and tissues in the lab. We offer biomaterials, equipment, and services to support tissue engineering and regenerative medicine. Our mission is to fabricate lab-grown tissues and organs, for both research and therapeutic applications.
Via Cantonale 18

Member

Viopas Venture Consulting GmbH

Viopas Venture Consulting supports investors and family offices with valuable decision criteria for investment opportunities in the healthcare sector and companies with a wide range of tailor-made services and advice such as fundraising, business strategy, licensing and M&A.
8620 Uster

Member

Limula SA

Limula SA is developing a platform technology to enable scale out of cell therapy manufacturing, directly at the point of care. We support companies at all stages of the life cycle of their therapies, from R&D to routine production.
La Tour-de-Peilz

Member